Market research
2CG2.F NanoSphere Health Sciences Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 2M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.21
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- Not available
- Market cap
- 2M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.21
About
About NanoSphere Health Sciences Inc
Nanosphere Health Sciences Inc., a nano-biotechnology company, focuses on providing next generation delivery of biologically active compounds in the United States and Canada. It offers NanoSphere Deliver System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The company is headquartered in Vancouver, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 2CG2.F discussion.
5 years, 5 months ago
NanoSphere Health Sciences Inc is currently in a long term downtrend where the price is trading 20.3% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
NanoSphere Health Sciences Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 92.6% to $-65K since the same quarter in the previous year.
Finally, its free cash flow fell by 99.2% to $2K since the same quarter in the previous year.
Based on the above factors, NanoSphere Health Sciences Inc gets an overall score of 2/5.